The Moscow authorities have announced the start of clinical trials of Sputnik light in the Russian capital. This is a simplified version of the Sputnik V, requiring only one injection instead of two.
On February 27, 2021, the first volunteers were vaccinated with Sputnik light in Moscow. This version of the Russian Sputnik V vaccine against Covid-19 only requires one injection, instead of two for current other vaccines.
The deputy mayor of the Russian capital Anastasia Rakova spoke about the situation in these terms: “Today, the first participants in the study of the anti-Covid Sputnik vaccine light have been vaccinated. As the volunteers are examined, the quantities of vaccinations will increase. Applications are filed by many people, 490 [d’entre elles] underwent a medical examination within two days. ” She also clarified that the Sputnik light would be used on individuals between the ages of 18 and 30, who develop a satisfactory immune response and produce enough antibodies from the first injection.
According to Moscow Mayor Sergei Sobyanin, around 6,000 volunteers will participate in the clinical trials – 3,000 Russians and 3,000 citizens of the United Arab Emirates – and these will be under medical supervision for six months. Sergei Sobyanin announced the start of the Sputnik tests light at the international level nine days earlier, on February 18.
According to the director of the Russian Direct Investment Fund, which finances Sputnik’s clinical studies light, the level of protection of this new version of the vaccine could reach 85%, and the immunity it provides could last three to four months. The Sputnik light would therefore be particularly suitable as an interim solution to major epidemic peaks requiring rapid vaccination.